Nektar Therapeutics | NKTR - DÍVIDA





DÍVIDA Alterar Data
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 57.32B 2.72B 2026-03
Baxter International USD 9.69B 93M 2026-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 8.09B 1.53B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Cara Therapeutics USD 0 0 2025-03
Cipla INR 6.14B 1.76B 2026-03
Dr.Reddys Laboratories INR 71.95B 5.39B 2026-06
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Exelixis USD 165.93M 3.61M 2026-06
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 36.51M 500K 2026-03
Merck USD 49.12B 222M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Takeda JPY 4.94T 58.13B 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Xencor USD 175.16M 12.58M 2026-03